PFE
Pfizer Inc
NYSE: PFE · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$26.70
+1.68% today
Updated 2026-04-30
Market cap
$149.38B
P/E ratio
19.31
P/S ratio
2.39x
EPS (TTM)
$1.36
Dividend yield
6.50%
52W range
$21 – $29
Volume
38.0M
Pfizer Inc (PFE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $114.84B | $115.27B | $111.15B | $212.95B | $195.01B | $188.00B | $185.80B | $172.10B | $169.27B | $167.46B | $171.62B | $171.80B | $159.42B | $167.49B | $154.23B | $181.48B | $197.21B | $226.50B | $213.40B | — |
| Cash & equivalents | $1.83B | $3.41B | $2.12B | $1.98B | $1.74B | $3.18B | $10.08B | $2.18B | $3.34B | $3.64B | $2.60B | $1.34B | $1.14B | $1.30B | $1.78B | $1.94B | $416.00M | $2.85B | $1.04B | — |
| Current assets | $46.95B | $46.85B | $43.08B | $61.67B | $60.47B | $57.73B | $61.41B | $56.24B | $57.70B | $43.80B | $38.95B | $41.14B | $49.93B | $32.80B | $35.07B | $59.69B | $51.26B | $43.33B | $50.36B | — |
| Total liabilities | $44.11B | $50.14B | $53.41B | $122.50B | $106.75B | $105.38B | $104.12B | $95.48B | $97.65B | $102.46B | $111.78B | $100.14B | $95.66B | $104.04B | $90.76B | $104.01B | $101.29B | $137.21B | $124.90B | $-93.10B |
| Current liabilities | $21.39B | $21.84B | $27.01B | $37.23B | $28.61B | $28.07B | $28.62B | $23.37B | $21.63B | $29.40B | $31.11B | $30.43B | $31.86B | $37.30B | $25.92B | $42.67B | $42.14B | $47.79B | $42.99B | — |
| Long-term debt | $5.55B | $7.31B | $7.96B | $43.19B | $38.41B | $34.93B | $31.04B | $30.46B | $31.54B | $28.82B | $31.40B | $33.54B | $32.91B | $35.95B | $37.13B | $36.20B | $32.88B | $60.50B | $56.70B | — |
| Shareholder equity | $71.36B | $65.01B | $57.56B | $90.01B | $87.81B | $82.19B | $81.26B | $76.31B | $71.30B | $64.72B | $59.54B | $71.31B | $63.41B | $63.14B | $63.24B | $77.20B | $95.66B | $89.01B | $88.20B | $93.10B |
| Retained earnings | $49.67B | $49.66B | $49.14B | $40.43B | $42.72B | $46.21B | $54.24B | $69.73B | $72.18B | $71.99B | $71.77B | $85.29B | $89.55B | $97.67B | $96.77B | $103.39B | $125.66B | $118.35B | $116.72B | — |
| Accounts receivable | $9.91B | $10.46B | $9.78B | $15.84B | $15.08B | $22.44B | $10.68B | $9.36B | $8.67B | $10.84B | $11.27B | $11.27B | $11.40B | $12.07B | $11.19B | $15.74B | $14.53B | $11.18B | $14.78B | — |
| Inventory | $6.11B | $5.30B | $4.38B | $12.40B | $8.40B | $7.77B | $7.06B | $6.17B | $5.66B | $7.51B | $6.78B | $7.58B | $7.51B | $8.28B | $8.05B | $9.06B | $8.98B | $10.19B | $10.85B | — |
| Goodwill | $20.88B | $21.38B | $21.46B | $42.38B | $43.95B | $45.07B | $44.67B | $42.52B | $42.07B | $48.24B | $54.45B | $55.95B | $53.41B | $58.65B | $49.58B | $49.21B | $51.38B | $67.78B | $68.53B | — |